Apomorphine and central serotonin neurons.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001545:Benserazide / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009046:Motor Neurons / Q000187:drug effects*; D009526:Nialamide / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000032:analysis / Q000502:physiology*; D013141:Spiro Compounds / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013997:Time Factors
D001565:Benzoates; D008996:Monoamine Oxidase Inhibitors; D013141:Spiro Compounds; D010868:Pimozide; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D001545:Benserazide; D006916:5-Hydroxytryptophan; D006220:Haloperidol; D001058:Apomorphine; D010134:Fenclonine; D009526:Nialamide